search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


12 resulaten gevonden voor CKTO in trials

Randomised Phase III Trial Comparing Concurrent Chemoradiation and Adjuvant Chemotherapy with Pelvic Radiation Alone in High Risk and Advanced Stage Endometrial Carcinoma: PORTEC-3.
- TRIAL ID
NTR729
- ACRONYMPORTEC-3
A randomized phase III study comparing induction chemotherapy to daily low dose Cisplatin both combined with high dose radiotherapy in patients with inoperable non-small cell lung cancer stage I, II and III.
- TRIAL ID
NTR514
- ACRONYMN/A
Efficacy of staging by sentinel lymph node procedure in vulvar cancer.
- TRIAL ID
NTR427
- ACRONYMN/A
Chemoradiation for irresectable (T4) esophageal cancer, a phase II multicenter study.
- TRIAL ID
NTR410
- ACRONYMT4
SC.20 / CKTO 2004-06 A phase III international randomised trial of singel versus multiple fractions for re-irradiation of painful bone metastases.
- TRIAL ID
NTR358
- ACRONYMMETRET (metastases retreatment trial)
Immediate optimal endocrine adjuvant therapy versus standard chemotherapy followed by the same endocrine therapy in pre- or perimenopausal patients with early hormone receptor-positive breast cancer the PROMISE study.
- TRIAL ID
NTR357
- ACRONYMPROMISE, BOOG 2002-01
PORTEC-2: Postoperative Radiation Therapy for Endometrial Carcinoma – a multicenter randomised phase III trial comparing external beam radiation and vaginal brachytherapy.
- TRIAL ID
NTR332
- ACRONYMPORTEC-2
Myelo-ablative chemo/radiotherapy and autologous stem cell transplantation as compared to only chemotherapy in patients with multiple myeloma.
- TRIAL ID
NTR321
- ACRONYMHOVON 24 MM
Effect of recombinant G-CSF on the results of chemotherapy (CHOP) in elderly patients with intermediate-/high-grade Non-Hodgkin’s Lymphoma. A prospective phase III study.
- TRIAL ID
NTR320
- ACRONYMHOVON 25 NHL
Risk adapted treatment of acute myelocytic leukemia (AML).
- TRIAL ID
NTR291
- ACRONYMHOVON 29 AML/SAKK 30/95
High-dose cytarabin versus low-dose cytarabin plus interferon-alpha-2a both followed by maintenance with interferon-alpha-2a in chronic myeloid leukemia.
- TRIAL ID
NTR290
- ACRONYMHOVON 38 CML
Radiation dose intensity study in breast cancer in young women: a randomized phase III trial of additional dose to the tumor bed.
- TRIAL ID
NTR120
- ACRONYMYoung Boost Trial